Molecular Biology Enzymes, Reagents, and Kits Market Size, Share, and Trends 2025 to 2034

The global molecular biology enzymes, reagents, and kits market is projected to grow from USD 27.68 billion in 2025 to USD 63.58 billion by 2034, exhibiting a CAGR of 9.68%. Market expansion is fueled by rising genomic applications, increasing demand for molecular diagnostics, personalized medicine, R&D investment, and innovations in next-generation sequencing and laboratory automation.

Last Updated : August 2025  |  Report Code : 5327  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Molecular Biology Enzymes, Reagents, and Kits Market 

5.1. COVID-19 Landscape: Molecular Biology Enzymes, Reagents, and Kits Industry Impact

5.2. COVID-19 - Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Molecular Biology Enzymes, Reagents, and Kits Market, By Product

8.1. Molecular Biology Enzymes, Reagents, and Kits Market Revenue and Volume, by Product

8.1.1 Kits and Reagents

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Enzymes

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Global Molecular Biology Enzymes, Reagents, and Kits Market, By Application

9.1. Molecular Biology Enzymes, Reagents, and Kits Market Revenue and Volume, by Application

9.1.1. Cloning

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Sequencing

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. PCR

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Epigenetics

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Restriction Digestion

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Other Applications

9.1.6.1. Market Revenue and Volume Forecast

Chapter 10. Global Molecular Biology Enzymes, Reagents, and Kits Market, By End-use

10.1. Molecular Biology Enzymes, Reagents, and Kits Market Revenue and Volume, by End-use

10.1.1. Pharma and Biotech

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Academic and Research

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Hospital and Diagnostics

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Molecular Biology Enzymes, Reagents, and Kits Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product

11.1.2. Market Revenue and Volume Forecast, by Application

11.1.3. Market Revenue and Volume Forecast, by End-use

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product

11.1.4.2. Market Revenue and Volume Forecast, by Application

11.1.4.3. Market Revenue and Volume Forecast, by End-use

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product

11.1.5.2. Market Revenue and Volume Forecast, by Application

11.1.5.3. Market Revenue and Volume Forecast, by End-use

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product

11.2.2. Market Revenue and Volume Forecast, by Application

11.2.3. Market Revenue and Volume Forecast, by End-use

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product

11.2.4.2. Market Revenue and Volume Forecast, by Application

11.2.4.3. Market Revenue and Volume Forecast, by End-use

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product

11.2.5.2. Market Revenue and Volume Forecast, by Application

11.2.5.3. Market Revenue and Volume Forecast, by End-use

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product

11.2.6.2. Market Revenue and Volume Forecast, by Application

11.2.6.3. Market Revenue and Volume Forecast, by End-use

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product

11.2.7.2. Market Revenue and Volume Forecast, by Application

11.2.7.3. Market Revenue and Volume Forecast, by End-use

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product

11.3.2. Market Revenue and Volume Forecast, by Application

11.3.3. Market Revenue and Volume Forecast, by End-use

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product

11.3.4.2. Market Revenue and Volume Forecast, by Application

11.3.4.3. Market Revenue and Volume Forecast, by End-use

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product

11.3.5.2. Market Revenue and Volume Forecast, by Application

11.3.5.3. Market Revenue and Volume Forecast, by End-use

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product

11.3.6.2. Market Revenue and Volume Forecast, by Application

11.3.6.3. Market Revenue and Volume Forecast, by End-use

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product

11.3.7.2. Market Revenue and Volume Forecast, by Application

11.3.7.3. Market Revenue and Volume Forecast, by End-use

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product

11.4.2. Market Revenue and Volume Forecast, by Application

11.4.3. Market Revenue and Volume Forecast, by End-use

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product

11.4.4.2. Market Revenue and Volume Forecast, by Application

11.4.4.3. Market Revenue and Volume Forecast, by End-use

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product

11.4.5.2. Market Revenue and Volume Forecast, by Application

11.4.5.3. Market Revenue and Volume Forecast, by End-use

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product

11.4.6.2. Market Revenue and Volume Forecast, by Application

11.4.6.3. Market Revenue and Volume Forecast, by End-use

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product

11.4.7.2. Market Revenue and Volume Forecast, by Application

11.4.7.3. Market Revenue and Volume Forecast, by End-use

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product

11.5.2. Market Revenue and Volume Forecast, by Application

11.5.3. Market Revenue and Volume Forecast, by End-use

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product

11.5.4.2. Market Revenue and Volume Forecast, by Application

11.5.4.3. Market Revenue and Volume Forecast, by End-use

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product

11.5.5.2. Market Revenue and Volume Forecast, by Application

11.5.5.3. Market Revenue and Volume Forecast, by End-use

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Illumina, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Agilent Technologies, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. QIAGEN

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Promega Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. New England Biolabs

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Merck KGaA

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. F. Hoffmann-La Roche Ltd.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Bio-Rad Laboratories, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Takara Bio, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global molecular biology enzymes, reagents, and kits market size is expected to grow from USD 25.24 billion in 2024 to USD 63.58 billion by 2034.

The molecular biology enzymes, reagents, and kits market is anticipated to grow at a CAGR of 9.68% between 2025 and 2034.

The major players operating in the molecular biology enzymes, reagents, and kits market are Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, Promega Corporation, New England Biolabs, Merck KGaA, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Takara Bio, Inc., LGC Limited, Bausch Health Companies Inc., and Others.

The driving factors of the molecular biology enzymes, reagents, and kits market are the increase in the use of molecular diagnostics also increased incidence of genetic diseases.

North America region will lead the global molecular biology enzymes, reagents, and kits market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client